Dexcom (DXCM) Non Operating Income (2016 - 2026)

Dexcom (DXCM) has 11 years of Non Operating Income data on file, last reported at $14.2 million in Q1 2026.

• Non Operating Income for Q1 2026 came in at $14.2 million, down 31.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $170.2 million (up 73.32% YoY), and the FY2025 annual result was $176.6 million, up 62.02% from the prior year.
• Non Operating Income fell to $14.2 million in Q1 2026 per DXCM's latest filing, from $17.7 million in the prior quarter.
• Over five years, Non Operating Income peaked at $109.8 million in Q3 2025 and troughed at -$1.3 million in Q3 2022.
• A 5-year average of $24.8 million and a median of $22.4 million in 2024 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income slumped 900.0% in 2022, then soared 2784.62% in 2023.
• A 5-year view of Non Operating Income shows it stood at $8.0 million in 2022, then soared by 266.25% to $29.3 million in 2023, then fell by 23.55% to $22.4 million in 2024, then fell by 20.98% to $17.7 million in 2025, then slipped by 19.77% to $14.2 million in 2026.
• Business Quant data shows DXCM's Non Operating Income at $14.2 million in Q1 2026, $17.7 million in Q4 2025, and $109.8 million in Q3 2025.